CIMP Research Publications

Ren L, Liu C, Çifcibaşı K, et al. Sensory neurons drive pancreatic cancer progression through glutamatergic neuron–cancer pseudo-synapses. Cancer Cell. 2025 Sep 25;S1535-6108(25)00395-2. doi: 10.1016/j.ccell.2025.09.003.

Adel Jensen L, Bækgaard CH, Larsen MB, et al. Preliminary evaluation of ShallowHRD performance compared to HRDetect in familial breast cancer tumors. Sci Rep. 2025 Aug 11;15(1):29442. doi: 10.1038/s41598-025-14122-9.

Inayatullah M, Dwivedi AK, Tiwari VK. Advances in single-cell omics: transformative applications in basic and clinical research. Curr Opin Cell Biol. 2025 Aug;95:102548. doi: 10.1016/j.ceb.2025.102548.

Do TTN, Block I, Burton M, et al. Multi-transcriptomics predicts clinical outcome in systemically untreated breast cancer patients with extensive follow-up. Breast Cancer Res. 2025 Jul 15;27(1):133. doi: 10.1186/s13058-025-02061-2.

Kostov AM, Jensen MB, Ejlertsen B, et al. Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study. Breast Cancer Res. Treat. 2025 Jul;212(2):309–323. doi: 10.1007/s10549-025-07726-2.

Munch AK, Feldner ES, Bækgaard CH, et al. Classification of gene variants in a Danish population with suspected predisposition to hereditary breast and/or ovarian cancer. Cancers (Basel). 2025 May 29;17(11):1819. doi: 10.3390/cancers17111819.

Stojanovic L, Abbotts R, Tripathi K, et al. ZNFX1 functions as a master regulator of epigenetically induced pathogen mimicry and inflammasome signaling in cancer. Cancer Res. 2025 Apr 3;85(7):1183–1198. doi: 10.1158/0008-5472.CAN-24-1286.

Kostov AM, Jensen MB, Ejlertsen B, et al. Germline BRCA testing in Denmark following invasive breast cancer: progress since 2000. Acta Oncol. 2025 Jan 28;64:147–155. doi: 10.2340/1651-226X.2025.42418.

Lusby R, Demirdizen E, Inayatullah M, et al. Pan-cancer drivers of metastasis. Mol Cancer. 2025 Jan 2;24(1):2. doi: 10.1186/s12943-024-02182-w.

Waede M, Kingo C, Damsbo K, et al. Phenotypic changes in a monocyte cluster with high interleukin-1 beta expression during long-term anti-CD20 therapy. Ann Neurol. 2025 Aug 29. doi: 10.1002/ana.78004.

Ngo A, Liu L, Larivière S, et al. Associations between epilepsy-related polygenic risk and brain morphology in childhood. Brain. 2025 Aug 14:awaf259. doi: 10.1093/brain/awaf259.

Dwivedi AK, Mahesh A, Sanfeliu A, et al. High-resolution multimodal profiling of human epileptic brain activity via explanted depth electrodes. JCI Insight. 2025 Jan 9;10(1):e184518. doi: 10.1172/jci.insight.184518.

Waede M, Voss LF, Kingo C, et al. Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti-CD20 therapy. Ann Clin Transl Neurol. 2024 Oct;11(10):2657–2672. doi: 10.1002/acn3.52182.

Elkjaer ML, Hartebrodt A, Oubounyt M, et al. Single-cell multi-omics map of cell type-specific mechanistic drivers of multiple sclerosis lesions. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200213. doi: 10.1212/NXI.0000000000200213.

El-Masri BM, Andreasen CM, Laursen KS, et al. Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. Bone Res. 2024;12:62. doi: 10.1038/s41413-024-00362-4.